ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 105 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,912,393 | -22.6% | 457,654 | +0.4% | 0.02% | -20.8% |
Q2 2022 | $12,804,360 | +4.0% | 455,684 | +70.8% | 0.02% | +41.2% |
Q1 2022 | $12,309,753 | +9.8% | 266,786 | +100.0% | 0.02% | -41.4% |
Q4 2021 | $11,213,000 | +27.7% | 133,392 | +1.2% | 0.03% | +16.0% |
Q3 2021 | $8,783,000 | -35.0% | 131,801 | -48.1% | 0.02% | +31.6% |
Q2 2021 | $13,506,000 | +89.8% | 253,890 | +54.8% | 0.02% | -13.6% |
Q1 2021 | $7,116,000 | -14.9% | 164,012 | +1.9% | 0.02% | -15.4% |
Q4 2020 | $8,361,000 | +63.9% | 160,970 | +3.1% | 0.03% | +44.4% |
Q3 2020 | $5,102,000 | -50.2% | 156,087 | -26.8% | 0.02% | -10.0% |
Q2 2020 | $10,242,000 | – | 213,286 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Decheng Capital Management III (Cayman), LLC | 1,824,583 | $39,520,000 | 14.33% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,301,771 | $49,857,000 | 4.79% |
Matrix Capital Management Company, LP | 9,199,973 | $199,271,000 | 3.81% |
Integral Health Asset Management, LLC | 550,000 | $11,913,000 | 2.31% |
Avidity Partners Management LP | 4,223,100 | $91,472,000 | 1.86% |
Affinity Asset Advisors, LLC | 170,000 | $3,682,000 | 1.03% |
Eventide Asset Management | 1,861,000 | $40,309,000 | 0.79% |
Sofinnova Investments, Inc. | 583,357 | $12,636,000 | 0.74% |
Nicholas Investment Partners, LP | 158,704 | $3,438,000 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 60,000 | $1,300,000 | 0.26% |